Matricelf
Highly Engaged Employees
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Golda Meir, Ness Ziona, IsraelPhone Number
+972 504057353Website
www.matricelf.comRevenue
<$5 MillionIndustry
About Matricelf
Matricelf Org Chart
Is Matricelf your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Matricelf has new funding data
Check if Matricelf has recently received funding, and reach out quickly before it becomes old news!
Click to see if Matricelf had a recent Job posting/layoffs
Check out if Matricelf is spiking on competitors!
Earning: See what the market has to say on Matricelf recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Matricelf
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Matricelf launches new products
Matricelf, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Matricelf is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Matricelf is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Matricelf.
Matricelf Tech Stack
A closer look at the technologies used by Matricelf
Matricelf News & Media
Matricelf Advances Toward First in Human Trial Following Successful GLP Safety Study Completion
TEL AVIV, Israel, June 17, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants for spinal cord injury, today announced the successful completion of its comprehensive GLP safety study for its engineered neural...Matricelf Advances Toward First in Human Trial with Initiation of GMP Manufacturing Program
TEL AVIV, Israel, June 9, 2026 /PRNewswire/ -- – Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants for spinal cord injury, today announced the initiation of GMP manufacturing activities at Sheba Medical Center's Advanced...Matricelf (TASE: MTLF) Enters Strategic Collaboration with Sheba Medical Center to Advance First in Human Clinical Program in Spinal Cord Injury
TEL AVIV, Israel, March 24, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing autologous engineered neural tissue therapies, today announced a strategic collaboration with Sheba Medical Center, Tel Hashomer, ranked 7th globally by Newsweek, to...Matricelf Ltd. (TASE: MTLF) Reports Positive RNA Sequencing Results Demonstrating Promising Safety Profile of Its Personalized Spinal Cord Implant
NESS ZIONA, Israel, March 4, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered neural tissue implants for the treatment of spinal cord injury, today announced positive results from advanced RNA sequencing analyses of its...
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Matricelf
Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for a range of medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction et al. The company... Read More